These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8001229)

  • 1. Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450.
    Williams ML; Lennard MS; Martin IJ; Tucker GT
    Carcinogenesis; 1994 Dec; 15(12):2733-8. PubMed ID: 8001229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.
    Crewe HK; Notley LM; Wunsch RM; Lennard MS; Gillam EM
    Drug Metab Dispos; 2002 Aug; 30(8):869-74. PubMed ID: 12124303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
    Boocock DJ; Maggs JL; Brown K; White IN; Park BK
    Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro.
    Boocock DJ; Maggs JL; White IN; Park BK
    Carcinogenesis; 1999 Jan; 20(1):153-60. PubMed ID: 9934863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic hypothesis for the cytochrome P450-catalyzed cis-trans isomerization of 4-hydroxytamoxifen: an unusual redox reaction.
    Gao L; Tu Y; Wegman P; Wingren S; Eriksson LA
    J Chem Inf Model; 2011 Sep; 51(9):2293-301. PubMed ID: 21870861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins.
    Dehal SS; Kupfer D
    Drug Metab Dispos; 1999 Jun; 27(6):681-8. PubMed ID: 10348797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues.
    Brown K; Brown JE; Martin EA; Smith LL; White IN
    Chem Res Toxicol; 1998 May; 11(5):527-34. PubMed ID: 9585484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.
    Osborne CK; Wiebe VJ; McGuire WL; Ciocca DR; DeGregorio MW
    J Clin Oncol; 1992 Feb; 10(2):304-10. PubMed ID: 1732430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
    Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
    Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of the alpha,beta-unsaturated ketones, chalcone and trans-4-phenyl-3-buten-2-one, by rat liver microsomes and estrogenic activity of the metabolites.
    Kohno Y; Kitamura S; Sanoh S; Sugihara K; Fujimoto N; Ohta S
    Drug Metab Dispos; 2005 Aug; 33(8):1115-23. PubMed ID: 15863696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile geometric isomerization of phenolic non-steroidal estrogens and antiestrogens: limitations to the interpretation of experiments characterizing the activity of individual isomers.
    Katzenellenbogen JA; Carlson KE; Katzenellenbogen BS
    J Steroid Biochem; 1985 May; 22(5):589-96. PubMed ID: 4010284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.
    Parte P; Kupfer D
    Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of hepatic steroid hydroxylation by tamoxifen, a series of tamoxifen analogues and related compounds.
    Reidy GF; Murray M
    Biochem Pharmacol; 1989 Jan; 38(1):195-9. PubMed ID: 2910300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.
    Sun D; Chen G; Dellinger RW; Duncan K; Fang JL; Lazarus P
    Breast Cancer Res; 2006; 8(4):R50. PubMed ID: 16884532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases.
    Nishiyama T; Ogura K; Nakano H; Ohnuma T; Kaku T; Hiratsuka A; Muro K; Watabe T
    Biochem Pharmacol; 2002 May; 63(10):1817-30. PubMed ID: 12034366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.